FDA Inspection 942495 — Prof. Johnny Mahlangu
The FDA completed an inspection of Prof. Johnny Mahlangu on August 28, 2015 in Johannesburg. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 28, 2015
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Johannesburg (South Africa)
Additional Details
Clinical Investigator (CI)